FURALAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Furalan, and what generic alternatives are available?
Furalan is a drug marketed by Chartwell Molecular and is included in one NDA.
The generic ingredient in FURALAN is nitrofurantoin. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Furalan
A generic version of FURALAN was approved as nitrofurantoin by IMPAX LABS INC on January 28th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FURALAN?
- What are the global sales for FURALAN?
- What is Average Wholesale Price for FURALAN?
Summary for FURALAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Patent Applications: | 6,113 |
| DailyMed Link: | FURALAN at DailyMed |
US Patents and Regulatory Information for FURALAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | FURALAN | nitrofurantoin | TABLET;ORAL | 080017-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Molecular | FURALAN | nitrofurantoin | TABLET;ORAL | 080017-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
